Search Orphan Drug Designations and Approvals
-
Generic Name: | miltefosine |
---|---|
Date Designated: | 03/18/2009 |
Orphan Designation: | Topical treatment of cutaneous lymphoma encompassing cutaneous manifestations of T-cell lymphoma and B-cell lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ExperGen Drug Development GmbH Hernalser Haupstrasse 24/16 Austria The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-